Cargando…
Combination of metformin and phenformin synergistically inhibits proliferation and hTERT expression in human breast cancer cells
OBJECTIVE(S): Breast cancer remains a global challenge, and further chemopreventive therapies are still immediately required. Emerging evidence has revealed the potent anti-cancer effects of biguanides, Metformin (MET) and phenformin (PHE). Thus, to explore an efficient chemopreventive strategy for...
Autores principales: | Jafari-Gharabaghlou, Davoud, Pilehvar-Soltanahmadi, Younes, Dadashpour, Mehdi, Mota, Ali, Vafajouy-Jamshidi, Soheila, Faramarzi, Leila, Rasouli, Sara, Zarghami, Nosratollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251396/ https://www.ncbi.nlm.nih.gov/pubmed/30483391 http://dx.doi.org/10.22038/IJBMS.2018.30460.7345 |
Ejemplares similares
-
Synergistic Growth Inhibitory Effects of Chrysin and Metformin Combination on Breast Cancer Cells through hTERT and Cyclin D1 Suppression
por: Rasouli, Sara, et al.
Publicado: (2018) -
Synergistic Anticancer Effects of Silibinin and Chrysin in T47D Breast Cancer Cells
por: Maasomi, Zahra Javan, et al.
Publicado: (2017) -
Development of a Magnetic Nanostructure for Co-delivery of Metformin and Silibinin on Growth of Lung Cancer Cells: Possible Action Through Leptin Gene and its Receptor Regulation
por: Salamni Javan, Elnaz, et al.
Publicado: (2022) -
Fabricating niosomal-PEG nanoparticles co-loaded with metformin and silibinin for effective treatment of human lung cancer cells
por: Salmani-Javan, Elnaz, et al.
Publicado: (2023) -
Design and Development of Nanostructured Co Delivery of Artemisinin and Chrysin for Targeting hTERT Gene Expression in Breast Cancer Cell Line: Possible Clinical Application in Cancer Treatment
por: Khoshravan Azar, Leila, et al.
Publicado: (2022)